Basic research is very useful, but it should be more geared toward application than it was before.

We don't know why, but there are some gradients of infection.

The center will be fully operational in two years' time, but probably in the middle of the year we will have a temporary laboratory of 4,000 square feet.

It's easier to learn things for life by the age of 12 and not the age of 18. This is just my guess.

The idea of the live-virus vaccine is to produce in a continuous way some viral antigens.

It's clear that prevention will never be sufficient. That's why we need a vaccine that will be safe.

Our goal is not to completely eradicate the infection - that would be very difficult - but to produce a vaccine that will prevent not infection but disease. I think this is more possible.